Antibody-based therapies in patients with acute lymphoblastic leukemia

著者: Dinner, Shira, Liedtke, Michaela
出版年 Hematology Am Soc Hematol Educ Program (2018)

Therapeutic targeting of MLL

著者: Liedtke, Michaela, Cleary, Michael L.
出版事項 2009

Inotuzumab ozogamicin: a CD22 mAb–drug conjugate for adult relapsed or refractory B-cell precursor acute lymphoblastic leukemia

著者: Yurkiewicz, Ilana R, Muffly, Lori, Liedtke, Michaela
出版年 Drug Des Devel Ther (2018)

CD93 marks a non-quiescent human leukemia stem cell population and is required for development of MLL-rearranged acute myeloid leukemia

著者: Iwasaki, Masayuki, Liedtke, Michaela, Gentles, Andrew J., Cleary, Michael L.
出版年 Cell Stem Cell (2015)

Effects of serum and plasma matrices on multiplex immunoassays

著者: Rosenberg-Hasson, Yael, Hansmann, Leo, Liedtke, Michaela, Herschmann, Iris, Maecker, Holden T.
出版年 Immunol Res (2014)

Clonal expansion and interrelatedness of distinct B-lineage compartments in multiple myeloma bone marrow

著者: Hansmann, Leo, Han, Arnold, Penter, Livius, Liedtke, Michaela, Davis, Mark M.
出版年 Cancer Immunol Res (2017)

Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6

著者: Liedtke, Michaela, Ayton, Paul M., Somervaille, Tim C. P., Smith, Kevin S., Cleary, Michael L.
出版事項 2010

Mass cytometry analysis shows that a novel memory phenotype B cell is expanded in multiple myeloma

著者: Hansmann, Leo, Blum, Lisa, Ju, Chia-Hsin, Liedtke, Michaela, Robinson, William H., Davis, Mark M.
出版年 Cancer Immunol Res (2015)

Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement

著者: Dinner, Shira, Witteles, Wesley, Afghahi, Anosheh, Witteles, Ronald, Arai, Sally, Lafayette, Richard, Schrier, Stanley L., Liedtke, Michaela
出版事項 2013

2532. Identifying Educational Needs and Improving Provider Knowledge Regarding the Management of Febrile Neutropenia

著者: Chang, Amy, Deresinski, Stan, Subramanian, Aruna, Medeiros, Bruno, PharmD, Emily Mui, Meng, Lina, Liedtke, Michaela, Holubar, Marisa
出版年 Open Forum Infect Dis (2019)

Single-cell mutational profiling enhances the clinical evaluation of AML MRD

著者: Ediriwickrema, Asiri, Aleshin, Alexey, Reiter, Johannes G., Corces, M. Ryan, Köhnke, Thomas, Stafford, Melissa, Liedtke, Michaela, Medeiros, Bruno C., Majeti, Ravindra
出版年 Blood Adv (2020)

Organ responses with daratumumab therapy in previously treated AL amyloidosis

著者: Chung, Alfred, Kaufman, Gregory P., Sidana, Surbhi, Eckhert, Erik, Schrier, Stanley L., Lafayette, Richard A., Arai, Sally, Witteles, Ronald M., Liedtke, Michaela
出版年 Blood Adv (2020)

Structural changes of corneal epithelium in belantamab-associated superficial keratopathy using anterior segment optical coherence tomography

著者: Matsumiya, Wataru, Karaca, Irmak, Ghoraba, Hashem, Akhavanrezayat, Amir, Mobasserian, Azadeh, Hassan, Muhammad, Regenold, Jonathan, Yasar, Cigdem, Liedtke, Michaela, Kitazawa, Koji, Nguyen, Quan Dong
出版年 Am J Ophthalmol Case Rep (2021)

Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia

著者: Liedtke, Michaela, Twist, Clare J., Medeiros, Bruno C., Gotlib, Jason R., Berube, Caroline, Bieber, Marcia M., Bhat, Neelima M., Teng, Nelson N., Coutre, Steven E.
出版事項 2012

Report of the Relapsed/Refractory Cohort of SWOG S0919: A Phase 2 Study of Idarubicin and Cytarabine in Combination with Pravastatin for Acute Myelogenous Leukemia (AML)

著者: Advani, Anjali S., Li, Hongli, Michaelis, Laura C., Medeiros, Bruno C., Liedtke, Michaela, List, Alan F., O’Dwyer, Kristen, Othus, Megan, Erba, Harry P., Appelbaum, Frederick R.
出版年 Leuk Res (2018)

Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia

著者: Pollyea, Daniel A., Zehnder, James, Coutre, Steve, Gotlib, Jason R., Gallegos, Leonel, Abdel-Wahab, Omar, Greenberg, Peter, Zhang, Bing, Liedtke, Michaela, Berube, Caroline, Levine, Ross, Mitchell, Beverly S., Medeiros, Bruno C.
出版事項 2013

Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long‐term survival follow‐up from the randomized, phase 3 INO...

著者: Kantarjian, Hagop M., DeAngelo, Daniel J., Stelljes, Matthias, Liedtke, Michaela, Stock, Wendy, Gökbuget, Nicola, O’Brien, Susan M., Jabbour, Elias, Wang, Tao, Liang White, Jane, Sleight, Barbara, Vandendries, Erik, Advani, Anjali S.
出版年 Cancer (2019)

Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden

著者: DeAngelo, Daniel J., Advani, Anjali S., Marks, David I., Stelljes, Matthias, Liedtke, Michaela, Stock, Wendy, Gökbuget, Nicola, Jabbour, Elias, Merchant, Akil, Wang, Tao, Vandendries, Erik, Neuhof, Alexander, Kantarjian, Hagop, O’Brien, Susan
出版年 Blood Cancer J (2020)

First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction

著者: Gertz, Morie A., Landau, Heather, Comenzo, Raymond L., Seldin, David, Weiss, Brendan, Zonder, Jeffrey, Merlini, Giampaolo, Schönland, Stefan, Walling, Jackie, Kinney, Gene G., Koller, Martin, Schenk, Dale B., Guthrie, Spencer D., Liedtke, Michaela
出版年 J Clin Oncol (2016)

Inotuzumab Ozogamicin Versus Standard Care for Acute Lymphoblastic Leukemia

著者: Kantarjian, Hagop M., DeAngelo, Daniel J., Stelljes, Matthias, Martinelli, Giovanni, Liedtke, Michaela, Stock, Wendy, Gökbuget, Nicola, O’Brien, Susan, Wang, Kongming, Wang, Tao, Paccagnella, M. Luisa, Sleight, Barbara, Vandendries, Erik, Advani, Anjali S.
出版年 N Engl J Med (2016)